Article Details

AstraZeneca and Neurimmune close exclusive global collaboration and licence agreement ...

Retrieved on: 2022-03-01 07:04:53

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca and Neurimmune close exclusive global collaboration and licence agreement .... View article details on hiswai:

Excerpt

Alexion, AstraZeneca's Rare Disease group, has closed an exclusive global collaboration and licence agreement with Neurimmune AG for NI006, an.

Article found on: www.miragenews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up